Hudson Pharmaceuticals Ltd.
↗Dhaka, Bangladesh
Hudson Pharmaceuticals Ltd. (HPL) is a well-established pharmaceutical manufacturer in Bangladesh, recognized for its focus on high-quality branded generic medicines. The company operates a state-of-the-art manufacturing facility in Gazipur, which is designed according to WHO-cGMP standards and utilizes modular concepts and automated technology to minimize human interaction during production.
HPL has a strong presence in the domestic market and is an active exporter, shipping products to numerous countries across Asia and Africa. The company is particularly noted for its specialized segments, including respiratory, ophthalmic, and injectable formulations, alongside a broad portfolio of common generics such as anti-ulcerants, antibiotics, and vitamins.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Revenue:$25M-$50M
Founded:1985
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Inhalers, Injectables
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Bangladesh Association of Pharmaceutical Industries (BAPI)
COMPETITION
Position:Niche Player
Competitors:Incepta Pharmaceuticals, Square Pharmaceuticals, Beximco Pharmaceuticals, Renata Limited, Aristopharma
LEADERSHIP
Key Executives:
SM Shafiuzzaman - Managing Director
LINKS
Website:hpl.com.bd
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Hudson Pharmaceuticals Ltd.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.